Business in Brief; Teva to Invest $700 Million in New Pain Drug

Mutual fund chief opposes shift in trading week; Printer trial drives up Nano Dimension shares; Bid to delist Keter Publishing from TASE fails; Leading indexes edge down in TASE trading.

comments Print
Teva to invest $700 million in new pain drug